Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Anthracyclines and the heart]

G P Mazzarello1, L Morra

  • 1Istituto Scientifico di Medicina Interna, Università, Genova.

Recenti Progressi in Medicina
|October 31, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Normal aging and cognition: the unacknowledged contribution of cerebrovascular risk factors.

Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition·2012
Same author

A genetic algorithms' approach to the exploration of parameter space in mesoscopic multicellular tumour spheroid models.

Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference·2007
Same author

Bridging the Gap between mesoscopic and macroscopic models: the case of multicellular tumor spheroids.

Physical review letters·2005
Same author

[Comparative study of mandibular growth and rotation in two sample groups treated according to the "Distal Active Concept" or the Edgewise technique].

L' Orthodontie francaise·2001
Same author

Tracheal aspirates in long-term mechanically ventilated patients. A human model of gram-negative infection and airway inflammation.

Chest·1995
Same author

Albuterol delivery in a model of mechanical ventilation. Comparison of metered-dose inhaler and nebulizer efficiency.

American journal of respiratory and critical care medicine·1995
Same journal

Recenti progressi in medicina·2026
Same journal

Recenti progressi in medicina·2026
Same journal

Recenti progressi in medicina·2026
Same journal

Recenti progressi in medicina·2026
Same journal

Recenti progressi in medicina·2026
Same journal

Recenti progressi in medicina·2026
See all related articles

Anthracycline chemotherapy can cause cardiotoxicity, even at lower doses. Strategies to prevent cardiac damage include extended drug administration, using less toxic analogs, or co-administering cardioprotective agents.

Area of Science:

  • Oncology
  • Cardiology
  • Pharmacology

Context:

  • Anthracyclines are highly effective chemotherapy agents.
  • Cardiotoxicity is a significant and dose-limiting side effect of anthracyclines.
  • Doxorubicin has a maximum recommended dose of 450-550 mg/m², but cardiotoxicity can occur below this threshold.

Purpose:

  • To review the cardiotoxicity associated with anthracycline chemotherapy.
  • To discuss diagnostic methods for anthracycline-induced cardiotoxicity.
  • To outline strategies for preventing and managing anthracycline cardiotoxicity.

Summary:

  • Cardiotoxicity is a major concern with anthracyclines, manifesting as reduced left ventricular ejection fraction and diastolic dysfunction.
  • Prevention strategies include extending drug infusion time, utilizing less cardiotoxic anthracycline analogs, and administering cardioprotective drugs like ICRF187.

Related Experiment Videos

  • Diagnosis involves echocardiography, angiocardiography, cardiac scintigraphy, tomography, and endomyocardial biopsy in select cases.
  • Therapy focuses on managing congestive heart failure with digitalis, diuretics, and ACE inhibitors.

    • Impact:

    • Early diagnosis and management of cardiotoxicity are crucial for patient outcomes.
    • Development of safer anthracycline analogs and cardioprotective strategies can improve cancer treatment tolerability.
    • Understanding cardiotoxicity mechanisms aids in personalized treatment approaches and risk stratification.